Lineage Cell Therapeutics Inc (STU:BT3)
€ 0.775 -0.005 (-0.64%) Market Cap: 146.73 Mil Enterprise Value: 113.89 Mil PE Ratio: 0 PB Ratio: 2.32 GF Score: 59/100

Lineage Cell Therapeutics Inc (STU:BT3) Transcripts

  • 1